Diagnostic Tools Blood Testing Drug Development Infection Prevention Artificial Intelligence Drug Innovation Reproductive Technology Gene Therapy Health Innovations Vaccine Development Antimalarial Compounds Diagnostic Innovations Cancer Treatment Technology mRNA Technology Gel Formation
Approved by both companies’ boards, the all-stock acquisition is slated to close in 2025 pending regulatory approval.